Results 241 to 250 of about 304,509 (373)

Nanotechnology in brain cancer treatment: The role of gold nanoparticles as therapeutic enhancers

open access: yesIbrain, EarlyView.
This review highlights the potential of gold nanoparticles (AuNPs) in overcoming the blood‐brain barrier (BBB) to improve brain tumor treatment. By enabling targeted drug delivery and enhancing therapies like radiotherapy, phototherapy, and chemotherapy, AuNPs offer a promising approach for safer, more effective treatments of glioblastoma and other ...
Simona Tarantino   +4 more
wiley   +1 more source

Exosomes, autophagy, and cancer: A complex triad

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Cancer remains one of the leading causes of death worldwide. Despite remarkable progress in prevention, diagnosis, and therapy, the incidence of certain types of cancer persists, urging the identification of clinically relevant biomarkers and the development of novel therapeutic strategies to improve clinical outcomes and overcome treatment ...
María Guerra‐Andrés   +2 more
wiley   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner   +7 more
wiley   +1 more source

Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes [PDF]

open access: bronze, 2004
Shih‐Chieh Hung   +6 more
openalex   +1 more source

Screening outcomes at second FIT screening in individuals with a first time negative FIT‐result or low‐risk adenomas: Results from a nationwide FIT screening program

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Fecal immunochemical test (FIT) screening is increasingly common as a population‐based screening tool for colorectal cancer (CRC). If the follow‐up colonoscopy after a positive FIT detects only low‐risk adenomas, those participants are recommended to continue biennial screenings, the same as people with negative FIT results.
Pernille Thordal Larsen   +4 more
wiley   +1 more source

Inhibition of AP-1 and Neoplastic Transformation by Fresh Apple Peel Extract [PDF]

open access: hybrid, 2004
Min Ding   +8 more
openalex   +1 more source

The estrobolome: Estrogen‐metabolizing pathways of the gut microbiome and their relation to breast cancer

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Increasing evidence links the gut microbiome to carcinogenesis. Disruptions in estrogen regulation by the estrobolome—gut microbiota with estrogen‐related functions—may promote breast cancer. However, precise information on estrobolome targets and their underlying mechanisms is limited. This review identifies relevant targets for measuring the
Ashley H. Larnder   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy